US Stock MarketDetailed Quotes

CDTX Cidara Therapeutics

Watchlist

13.0899
+0.0899+0.69%

Close Nov 1 16:00 ET

92.13MMarket Cap-523P/E (TTM)

Cidara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

-94.07%302K

-67.58%8.46M

-0.84%63.91M

69.41%17.58M

-68.79%12.72M

-18.11%5.09M

267.24%26.11M

30.01%64.45M

43.65%10.38M

475.81%40.74M

Operating revenue

-94.07%302K

-67.58%8.46M

-0.84%63.91M

69.41%17.58M

-68.79%12.72M

-18.11%5.09M

267.24%26.11M

30.01%64.45M

43.65%10.38M

475.81%40.74M

Cost of revenue

1.56M

1.52M

1.14M

387K

Gross profit

-73.57%6.9M

-3.21%62.38M

58.46%16.45M

-69.74%12.33M

26.11M

64.45M

10.38M

40.74M

Operating expense

-3.67%11.4M

-24.59%17.59M

-11.32%86.87M

-17.90%22.52M

-19.11%20.89M

-38.76%11.84M

-8.06%23.33M

6.67%97.95M

14.32%27.43M

2.82%25.82M

Selling and administrative expenses

49.20%4.75M

34.57%6M

-10.77%18.33M

30.63%7.17M

-38.48%3.56M

-21.92%3.18M

-14.35%4.46M

9.64%20.55M

10.16%5.49M

25.46%5.78M

-General and administrative expense

49.20%4.75M

34.57%6M

-10.77%18.33M

30.63%7.17M

-38.48%3.56M

-21.92%3.18M

-14.35%4.46M

9.64%20.55M

10.16%5.49M

25.46%5.78M

Research and development costs

-23.10%6.66M

-38.56%11.59M

-11.46%68.53M

-30.04%15.35M

-13.53%17.33M

-43.25%8.66M

-6.43%18.87M

5.91%77.41M

15.41%21.94M

-2.26%20.04M

Operating profit

-64.51%-11.1M

-484.43%-10.69M

26.92%-24.48M

64.38%-6.07M

-157.33%-8.56M

48.54%-6.75M

115.23%2.78M

20.71%-33.5M

-1.68%-17.05M

182.74%14.92M

Net non-operating interest income expense

184.75%1.77M

57.33%365K

944.50%2M

225.31%527K

1,014.55%613K

10,483.33%623K

1,260.00%232K

190.09%191K

590.91%162K

217.02%55K

Non-operating interest income

----

57.33%365K

944.50%2M

225.31%527K

1,014.55%613K

----

--232K

--191K

--162K

--55K

Total other finance cost

-184.75%-1.77M

----

-10,483.33%-623K

----

Other net income (expense)

-84.88M

Special income (charges)

---84.88M

----

--0

----

-Less:Other special charges

--84.88M

----

Income before tax

-1,438.12%-94.21M

-442.71%-10.33M

32.49%-22.49M

67.16%-5.55M

-153.02%-7.94M

53.31%-6.13M

116.48%3.01M

21.56%-33.31M

-0.52%-16.89M

182.83%14.98M

Income tax

62.87%443K

-76.47%64K

230K

40K

272K

Net income

-569.47%-91.21M

-442.71%-10.33M

31.72%-22.93M

67.31%-5.61M

-154.56%-8.17M

-3.85%-13.62M

116.48%3.01M

20.92%-33.58M

-2.14%-17.16M

182.83%14.98M

Net income continuous Operations

-1,428.14%-94.21M

-442.71%-10.33M

31.72%-22.93M

67.31%-5.61M

-154.56%-8.17M

53.01%-6.17M

116.48%3.01M

20.92%-33.58M

-2.14%-17.16M

182.83%14.98M

Net income discontinuous operations

140.23%3M

----

---7.46M

----

Minority interest income

Net income attributable to the parent company

-569.47%-91.21M

-442.71%-10.33M

31.72%-22.93M

67.31%-5.61M

-154.56%-8.17M

-3.85%-13.62M

116.48%3.01M

20.92%-33.58M

-2.14%-17.16M

182.83%14.98M

Preferred stock dividends

Other preferred stock dividends

636K

3.08M

Net income attributable to common stockholders

-569.47%-91.21M

-534.41%-10.33M

31.72%-22.93M

67.31%-5.61M

-168.69%-8.17M

-3.85%-13.62M

113.00%2.38M

20.92%-33.58M

-2.14%-17.16M

165.79%11.9M

Basic earnings per share

-561.92%-19.99

-480.00%-2.28

45.83%-5.2

68.42%-1.2

-152.94%-1.8

20.53%-3.02

111.11%0.6

40.74%-9.6

26.92%-3.8

145.95%3.4

Diluted earnings per share

-561.92%-19.99

-480.00%-2.28

45.83%-5.2

68.42%-1.2

-152.94%-1.8

20.53%-3.02

111.11%0.6

40.74%-9.6

26.92%-3.8

145.95%3.4

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	-94.07%302K	-67.58%8.46M	-0.84%63.91M	69.41%17.58M	-68.79%12.72M	-18.11%5.09M	267.24%26.11M	30.01%64.45M	43.65%10.38M	475.81%40.74M
Operating revenue	-94.07%302K	-67.58%8.46M	-0.84%63.91M	69.41%17.58M	-68.79%12.72M	-18.11%5.09M	267.24%26.11M	30.01%64.45M	43.65%10.38M	475.81%40.74M
Cost of revenue		1.56M	1.52M	1.14M	387K		0	0	0	0
Gross profit		-73.57%6.9M	-3.21%62.38M	58.46%16.45M	-69.74%12.33M		26.11M	64.45M	10.38M	40.74M
Operating expense	-3.67%11.4M	-24.59%17.59M	-11.32%86.87M	-17.90%22.52M	-19.11%20.89M	-38.76%11.84M	-8.06%23.33M	6.67%97.95M	14.32%27.43M	2.82%25.82M
Selling and administrative expenses	49.20%4.75M	34.57%6M	-10.77%18.33M	30.63%7.17M	-38.48%3.56M	-21.92%3.18M	-14.35%4.46M	9.64%20.55M	10.16%5.49M	25.46%5.78M
-General and administrative expense	49.20%4.75M	34.57%6M	-10.77%18.33M	30.63%7.17M	-38.48%3.56M	-21.92%3.18M	-14.35%4.46M	9.64%20.55M	10.16%5.49M	25.46%5.78M
Research and development costs	-23.10%6.66M	-38.56%11.59M	-11.46%68.53M	-30.04%15.35M	-13.53%17.33M	-43.25%8.66M	-6.43%18.87M	5.91%77.41M	15.41%21.94M	-2.26%20.04M
Operating profit	-64.51%-11.1M	-484.43%-10.69M	26.92%-24.48M	64.38%-6.07M	-157.33%-8.56M	48.54%-6.75M	115.23%2.78M	20.71%-33.5M	-1.68%-17.05M	182.74%14.92M
Net non-operating interest income expense	184.75%1.77M	57.33%365K	944.50%2M	225.31%527K	1,014.55%613K	10,483.33%623K	1,260.00%232K	190.09%191K	590.91%162K	217.02%55K
Non-operating interest income	----	57.33%365K	944.50%2M	225.31%527K	1,014.55%613K	----	--232K	--191K	--162K	--55K
Total other finance cost	-184.75%-1.77M	----	----	----	----	-10,483.33%-623K	----	----	----	----
Other net income (expense)	-84.88M
Special income (charges)	---84.88M	----	----	----	----	--0	----	----	----	----
-Less:Other special charges	--84.88M	----	----	----	----	----	----	----	----	----
Income before tax	-1,438.12%-94.21M	-442.71%-10.33M	32.49%-22.49M	67.16%-5.55M	-153.02%-7.94M	53.31%-6.13M	116.48%3.01M	21.56%-33.31M	-0.52%-16.89M	182.83%14.98M
Income tax	0		62.87%443K	-76.47%64K	230K	40K		272K	272K	0
Net income	-569.47%-91.21M	-442.71%-10.33M	31.72%-22.93M	67.31%-5.61M	-154.56%-8.17M	-3.85%-13.62M	116.48%3.01M	20.92%-33.58M	-2.14%-17.16M	182.83%14.98M
Net income continuous Operations	-1,428.14%-94.21M	-442.71%-10.33M	31.72%-22.93M	67.31%-5.61M	-154.56%-8.17M	53.01%-6.17M	116.48%3.01M	20.92%-33.58M	-2.14%-17.16M	182.83%14.98M
Net income discontinuous operations	140.23%3M	----	----	----	----	---7.46M	----	----	----	----
Minority interest income
Net income attributable to the parent company	-569.47%-91.21M	-442.71%-10.33M	31.72%-22.93M	67.31%-5.61M	-154.56%-8.17M	-3.85%-13.62M	116.48%3.01M	20.92%-33.58M	-2.14%-17.16M	182.83%14.98M
Preferred stock dividends
Other preferred stock dividends		0			0		636K			3.08M
Net income attributable to common stockholders	-569.47%-91.21M	-534.41%-10.33M	31.72%-22.93M	67.31%-5.61M	-168.69%-8.17M	-3.85%-13.62M	113.00%2.38M	20.92%-33.58M	-2.14%-17.16M	165.79%11.9M
Basic earnings per share	-561.92%-19.99	-480.00%-2.28	45.83%-5.2	68.42%-1.2	-152.94%-1.8	20.53%-3.02	111.11%0.6	40.74%-9.6	26.92%-3.8	145.95%3.4
Diluted earnings per share	-561.92%-19.99	-480.00%-2.28	45.83%-5.2	68.42%-1.2	-152.94%-1.8	20.53%-3.02	111.11%0.6	40.74%-9.6	26.92%-3.8	145.95%3.4
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data